Cargando…
Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA
INTRODUCTION: Deficiencies in interleukin (IL)-1 receptor (IL-R) antagonist (DIRA) and IL-36R antagonist (DITRA) are rare genetic autoinflammatory diseases related to alterations in antagonists of the IL-1 pathway. IL-1 antagonists may represent therapeutic alternatives. Here, we aim to provide a sc...
Autores principales: | Gómez-García, Francisco, Sanz-Cabanillas, Juan L., Viguera-Guerra, Isabel, Isla-Tejera, Beatriz, Nieto, Antonio Vélez-García, Ruano, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261121/ https://www.ncbi.nlm.nih.gov/pubmed/30392030 http://dx.doi.org/10.1007/s13555-018-0269-7 |
Ejemplares similares
-
Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
por: Gómez-García, Francisco, et al.
Publicado: (2019) -
A Scoping Review Protocol to Explore the Use of Interleukin-1-Targeting Drugs for the Treatment of Dermatological Diseases: Indications, Mechanism of Action, Efficacy, and Safety
por: Gómez-García, Francisco, et al.
Publicado: (2018) -
Evolution of international collaborative research efforts to develop non-Cochrane systematic reviews
por: Viguera-Guerra, Isabel, et al.
Publicado: (2019) -
Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents
por: Hospach, Toni, et al.
Publicado: (2019) -
Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
por: Montilla, Ana M., et al.
Publicado: (2019)